Brief: Biostage announces use of its Esophageal Implant product candidate in a patient
Aug 7 (Reuters) - Biostage Inc BSTG.O
* Biostage announces use of its Esophageal Implant product
candidate in a patient
Source text for Eikon: ID:nPn7k5lKva
Further company coverage: BSTG.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Harvard Apparatus Regenerative Technology
See all newsBrief: Harvard Apparatus Regenerative Technology Announces Strategic Collaboration With Children’S Hospital Capital Institute Of Pediatrics In Beijing, China To Advance Treatment For Esophageal Atresia
Brief: Biostage Activated Mayo Clinic As The First Site For Clinical Trial In Severe Esophageal Disease
Brief: Biostage Amends CEO Employment Agreement
Brief: Biostage Inc Files For Firm Commitment Public Offering Of 1.03 Million Units - SEC Filing
Brief: Biostage Announces Appointment Of New Chief Financial Officer